ScripThe big respiratory players will be casting envious glances at the launch of Verona Pharma’s chronic obstructive pulmonary disorder (COPD) drug, Ohtuvayre, which is going from strength to strength. Th
ScripIt was eight years ago during the J.P. Morgan Healthcare conference that Donald Trump accused pharmaceutical manufacturers of “getting away with murder,” just days before being inaugurated US presiden
Pink SheetThe Equitable Breakthroughs in Medicine Development (EQBMED) pilot program’s lessons for bringing clinical trials to underserved areas could help inform sponsors’ trial diversity actions, which are ex
ScripOnce a key part of its next-generation plans in cancer, Merck & Co . has called a halt to the last remaining Phase III studies of its TIGIT- and LAG-3 targeting immunotherapy assets. The two immu